Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 4442.33 | 21 / 21 | 100% | 18.67 | 504 / 504 |
esophagus | 100% | 4680.04 | 1445 / 1445 | 100% | 20.98 | 183 / 183 |
intestine | 100% | 4710.06 | 966 / 966 | 100% | 15.18 | 527 / 527 |
lung | 100% | 5989.80 | 578 / 578 | 100% | 18.67 | 1155 / 1155 |
ovary | 100% | 5152.61 | 180 / 180 | 100% | 15.60 | 430 / 430 |
skin | 100% | 7083.30 | 1809 / 1809 | 100% | 15.45 | 472 / 472 |
stomach | 100% | 3585.30 | 359 / 359 | 100% | 14.08 | 286 / 286 |
uterus | 100% | 5342.03 | 170 / 170 | 100% | 25.10 | 459 / 459 |
breast | 100% | 5632.32 | 459 / 459 | 100% | 18.24 | 1117 / 1118 |
prostate | 100% | 4628.30 | 245 / 245 | 100% | 12.72 | 501 / 502 |
thymus | 100% | 4664.41 | 653 / 653 | 100% | 18.83 | 603 / 605 |
kidney | 100% | 3695.30 | 89 / 89 | 99% | 14.55 | 896 / 901 |
adrenal gland | 100% | 6819.26 | 258 / 258 | 99% | 13.59 | 228 / 230 |
pancreas | 99% | 2663.60 | 326 / 328 | 99% | 19.87 | 177 / 178 |
brain | 98% | 2676.20 | 2588 / 2642 | 100% | 13.05 | 705 / 705 |
liver | 100% | 2194.69 | 226 / 226 | 95% | 7.91 | 385 / 406 |
adipose | 100% | 5850.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.93 | 29 / 29 |
muscle | 100% | 3655.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6461.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.00 | 1 / 1 |
blood vessel | 100% | 4291.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2607.39 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 3418.55 | 887 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 9.08 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051301 | Biological process | cell division |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007084 | Biological process | mitotic nuclear membrane reassembly |
GO_0050790 | Biological process | regulation of catalytic activity |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0042326 | Biological process | negative regulation of phosphorylation |
GO_0007417 | Biological process | central nervous system development |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0051721 | Molecular function | protein phosphatase 2A binding |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ANKLE2 |
Protein name | Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) ANKLE2 Ankyrin repeat and LEM domain containing 2 |
Synonyms | KIAA0692 LEM4 |
Description | FUNCTION: Involved in mitotic nuclear envelope reassembly by promoting dephosphorylation of BAF/BANF1 during mitotic exit . Coordinates the control of BAF/BANF1 dephosphorylation by inhibiting VRK1 kinase and promoting dephosphorylation of BAF/BANF1 by protein phosphatase 2A (PP2A), thereby facilitating nuclear envelope assembly . May regulate nuclear localization of VRK1 in non-dividing cells . It is unclear whether it acts as a real PP2A regulatory subunit or whether it is involved in recruitment of the PP2A complex . Involved in brain development . . |
Accessions | ENST00000535036.5 Q86XL3 A0A220T1R9 F5H6J0 ENST00000357997.10 [Q86XL3-1] ENST00000538766.1 F5H1D4 ENST00000542657.5 [Q86XL3-3] ENST00000542282.5 [Q86XL3-3] |